Revelation Biosciences Statistics
NASDAQ: REVBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.7921-0.036 (-4.35%)
Market open · Delayed 15 min · as of Oct 8, 12:30 PM ET
Revelation Biosciences by the numbers
Revelation Biosciences has a market capitalization of $3.2 million based on 3.98M shares outstanding. Its trailing P/E ratio is 0.2. The stock trades 19.8% below its 50-day average and 43.9% below its 200-day average.
Average daily trading volume is 39.03K shares, or about $30,920 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
REVB valuation vs. peer median
| Metric | REVB | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.16M | $3.29M | -4% |
| Avg. volume | 39.03K | 177.77K | -78% |
Peer median across 8 companies: MBIO, XRTX, CMND, CVKD, KAPA, APVO, SXTP, HCWB.
Valuation
- Market cap
- $3.16M
- P/E (TTM)
- 0.17
- EPS (TTM)
- $4.60
- Shares outstanding
- 3.98M
Price and trading
- Previous close
- 0.8281
- Open
- 0.81
- Day range
- 0.787 – 0.81
- 52-week range
- 0.75 – 6.24
- 50-day moving average
- 0.9878
- Beta
- —
- Volume
- 39.82K
- Average volume
- 39.03K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 3.16M
- Pe
- 0.17
- Forward Pe
- -0.27
- Eps
- 4.60
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.24
- Week52 Low
- 0.75
- Avg Volume
- 39,035.00
- Shares Outstanding
- 3.98M
- Ma50
- 0.99
- Ma200
- 1.41
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -87.31%
- Pct From52w Low
- 5.61%